Clinical Trial Update: A Study of Carbon 13-based Deep Labelling of Bone Marrow Cells

View source ↗

Summary

Mayo Clinic reports a clinical trial investigating carbon-13–based deep labelling of bone marrow cells, currently enrolling by invitation for MGUS and Non-IgM M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monoclonal Gammopathy of Undetermined Significance
• Non-igm Monoclonal Gammopathy of Undetermined Significance

Snippet

Sponsor: Mayo Clinic | Conditions: Monoclonal Gammopathy of Undetermined Significance (MGUS), Non-IgM Monoclonal Gammopathy of Undetermined Significance | Status: ENROLLING_BY_INVITATION